Product
Ifetroban Sodium
1 clinical trial
2 indications
Indication
Cardiovascular DiseasesIndication
Vascular DilationClinical trial
The Thromboxane Receptor Antagonist to Blunt the Effects of Non-Platelet Thromboxane Generation and Improve Endothelial Cell Function (TRAP) TrialStatus: Active (not recruiting), Estimated PCD: 2022-11-07